QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
NASDAQ:MNMD

Mind Medicine (MindMed) - MNMD Earnings Date, Estimates & Call Transcripts

1.02
+0.27 (+36.18%)
(As of 08/18/2022 05:45 PM ET)
Add
Compare
Today's Range
0.90
1.33
50-Day Range
0.58
0.85
52-Week Range
0.53
2.97
Volume
227.68 million shs
Average Volume
4.91 million shs
Market Capitalization
$430.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
5.00

Earnings Summary

Upcoming
Earnings Date
Nov. 11Estimated
Actual EPS
(May. 16)
-0.04 Beat By 0.01
Consensus EPS
(May. 16)
-0.05
Last Year's Q2 EPS
(5/14/2021)
-0.04
Skip Charts & View Estimated and Actual Earnings Data

MNMD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MNMD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Mind Medicine (MindMed) Analyst Forecasts

Current Year EPS Consensus Estimate: $-0.17 EPS
Next Year EPS Consensus Estimate: $-0.2 EPS

MNMD Earnings Date and Information

Mind Medicine (MindMed) last released its quarterly earnings data on May 16th, 2022. The reported -0.04 earnings per share for the quarter, topping the consensus estimate of -0.05 by 0.01. Mind Medicine (MindMed) has generated -0.18 earnings per share over the last year (-0.18 diluted earnings per share). Earnings for Mind Medicine (MindMed) are expected to decrease in the coming year, from -0.17 to -0.20 per share. Mind Medicine (MindMed) has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 11th, 2022 based off prior year's report dates.

Mind Medicine (MindMed) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/11/2022
(Estimated)
        
5/16/2022Q1 2022-0.05-0.04+0.01-0.04
3/28/2022Q4 2021-0.04-0.04-0.04    
11/12/2021Q3 2021-0.03-0.06-0.03-0.06
8/12/2021Q2 2021-0.04-0.09-0.05-0.09
5/14/2021Q1 2021-0.04-0.04-0.04
3/29/2021Q4 2020-0.01-0.01-0.01
11/12/2020Q3 2020-0.03-0.03-0.03
8/13/2020Q2 2020-0.02-0.02-0.02












Mind Medicine (MindMed) Earnings - Frequently Asked Questions

When is Mind Medicine (MindMed)'s earnings date?

Mind Medicine (MindMed) has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 11th, 2022 based off last year's report dates. Learn more on MNMD's earnings history.

Did Mind Medicine (MindMed) beat their earnings estimates last quarter?

In the previous quarter, Mind Medicine (MindMed) (NASDAQ:MNMD) reported -0.04 earnings per share (EPS) to beat the analysts' consensus estimate of -0.05 by 0.01. Learn more on analysts' earnings estimate vs. MNMD's actual earnings.

How much profit does Mind Medicine (MindMed) generate each year?

Mind Medicine (MindMed) (NASDAQ:MNMD) has a recorded net income of -$93.04 million. MNMD has generated -0.18 earnings per share over the last four quarters.

What is Mind Medicine (MindMed)'s EPS forecast for next year?

Mind Medicine (MindMed)'s earnings are expected to decrease from -0.17 per share to -0.20 per share in the next year.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:MNMD) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.